Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
Sponsor
University Hospital, Caen (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05563883
Collaborator
University Hospital, Tours (Other)
5,000,000
1
87.3
57256.4
Study Details
Study Description
Brief Summary
Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known.
The objective of this study is to use a very large French nationwide cohort to adress thèses questions.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
5000000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
Actual Study Start Date
:
Sep 22, 2022
Anticipated Primary Completion Date
:
Jan 1, 2030
Anticipated Study Completion Date
:
Jan 1, 2030
Outcome Measures
Primary Outcome Measures
- atrial fibrillation [from inclusion in the cohort up to 10 years]
occurrence of atrial fibrillation
- cancer [ffrom inclusion in the cohort up to 10 years]
occurrence of cancer
Secondary Outcome Measures
- thromboembolism [from inclusion in the cohort up to 10 years]
occurrence of thromboembolism
- bleeding [from inclusion in the cohort up to 10 years]
occurrence of bleeding
- mortality [from inclusion in the cohort up to 10 years]
occurrence of mortality
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
-
adult hospitalized patients
-
with an ICD-10 code discharge from january 2010 to december 2019 in the French national hospital discharge database (PMSI Programme de Médicalisation des Systèmes d'Information)
Exclusion Criteria:
- children
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Service de Cardiologie, Centre Hospitalier Universitaire Trousseau | Tours | France | 37000 |
Sponsors and Collaborators
- University Hospital, Caen
- University Hospital, Tours
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Joachim ALEXANDRE,
Prof,
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT05563883
Other Study ID Numbers:
- PMSI_092022
First Posted:
Oct 3, 2022
Last Update Posted:
Oct 3, 2022
Last Verified:
Sep 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: